BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 23460013)

  • 1. Management of nontuberculous mycobacterial (NTM) lung disease.
    Philley JV; Griffith DE
    Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atypical mycobacteria and pulmonary involvement in infectious diseases].
    Camarena MiƱana JJ; Pellicer RG
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():66-75. PubMed ID: 22305672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.
    Philley JV; Griffith DE
    Thorac Surg Clin; 2019 Feb; 29(1):65-76. PubMed ID: 30454923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
    Haworth CS; Floto RA
    Thorax; 2017 Nov; 72(11):969-970. PubMed ID: 29054887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of slowly growing mycobacteria.
    Philley JV; Griffith DE
    Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontuberculous mycobacteria in patients with cystic fibrosis.
    Leung JM; Olivier KN
    Semin Respir Crit Care Med; 2013 Feb; 34(1):124-34. PubMed ID: 23460012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials.
    Aksamit TR; Philley JV; Griffith DE
    Respir Med; 2014 Mar; 108(3):417-25. PubMed ID: 24484653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
    Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
    J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of a single isolation of pathogenic nontuberculous mycobacteria from sputum specimens.
    Koh WJ; Chang B; Ko Y; Jeong BH; Hong G; Park HY; Jeon K; Lee NY
    Diagn Microbiol Infect Dis; 2013 Feb; 75(2):225-6. PubMed ID: 23140755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
    Gitti Z; Mantadakis E; Maraki S; Samonis G
    Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.
    Henkle E; Aksamit T; Barker A; Daley CL; Griffith D; Leitman P; Leitman A; Malanga E; Marras TK; Olivier KN; Prevots DR; Prieto D; Quittner AL; Skach W; Walsh JW; Winthrop KL;
    Ann Am Thorac Soc; 2016 Sep; 13(9):S379-84. PubMed ID: 27627485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease.
    Ying C; Zhang L; Jin X; Zhu D; Wu W
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116254. PubMed ID: 38492490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.
    Somoskovi A; Salfinger M
    Clin Lab Med; 2014 Jun; 34(2):271-95. PubMed ID: 24856528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and drug susceptibility test of nontuberculous mycobacterial lung disease].
    Lou H; Sun Q; Gu J; Yang H; Hao XH; Xiao HP; Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):901-906. PubMed ID: 31826533
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of rapidly growing mycobacterial infections.
    Kasperbauer SH; De Groote MA
    Clin Chest Med; 2015 Mar; 36(1):67-78. PubMed ID: 25676520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.
    Kendall BA; Winthrop KL
    Semin Respir Crit Care Med; 2013 Feb; 34(1):87-94. PubMed ID: 23460008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.